Protective Efficacy in a Hamster Model of a Multivalent Vaccine for Human Visceral Leishmaniasis (MuLeVaClin) Consisting of the KMP11, LEISH-F3+, and LJL143 Antigens in Virosomes, Plus GLA-SE Adjuvant.

MLA

Fernández, Laura, et al. “Protective Efficacy in a Hamster Model of a Multivalent Vaccine for Human Visceral Leishmaniasis (MuLeVaClin) Consisting of the KMP11, LEISH-F3+, and LJL143 Antigens in Virosomes, Plus GLA-SE Adjuvant.” Microorganisms, vol. 9, no. 11, Oct. 2021. EBSCOhost, https://doi.org/10.3390/microorganisms9112253.

APA

Fernández, L., Solana, J. C., Sánchez, C., Jiménez, M. Á., Requena, J. M., Coler, R., Reed, S. G., Valenzuela, J. G., Kamhawi, S., Oliveira, F., Fichera, E., Glueck, R., Bottazzi, M. E., Gupta, G., Cecilio, P., Pérez-Cabezas, B., Cordeiro-da-Silva, A., Gradoni, L., Carrillo, E., & Moreno, J. (2021). Protective Efficacy in a Hamster Model of a Multivalent Vaccine for Human Visceral Leishmaniasis (MuLeVaClin) Consisting of the KMP11, LEISH-F3+, and LJL143 Antigens in Virosomes, Plus GLA-SE Adjuvant. Microorganisms, 9(11). https://doi.org/10.3390/microorganisms9112253

Chicago

Fernández, Laura, Jose Carlos Solana, Carmen Sánchez, Mª Ángeles Jiménez, Jose M Requena, Rhea Coler, Steven G Reed, et al. 2021. “Protective Efficacy in a Hamster Model of a Multivalent Vaccine for Human Visceral Leishmaniasis (MuLeVaClin) Consisting of the KMP11, LEISH-F3+, and LJL143 Antigens in Virosomes, Plus GLA-SE Adjuvant.” Microorganisms 9 (11). doi:10.3390/microorganisms9112253.